Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Current Deferred Revenue (2020 - 2024)

Historic Current Deferred Revenue for National Healthcare (NHC) over the last 7 years, with Q1 2024 value amounting to $7.7 million.

  • National Healthcare's Current Deferred Revenue changed N/A to $7.7 million in Q1 2024 from the same period last year, while for Mar 2024 it was $7.7 million, marking a year-over-year change of. This contributed to the annual value of $15.0 million for FY2021, which is 7069.05% down from last year.
  • Latest data reveals that National Healthcare reported Current Deferred Revenue of $7.7 million as of Q1 2024.
  • National Healthcare's 5-year Current Deferred Revenue high stood at $51.3 million for Q3 2020, and its period low was $138000.0 during Q3 2022.
  • In the last 4 years, National Healthcare's Current Deferred Revenue had a median value of $27.0 million in 2021 and averaged $27.3 million.
  • Per our database at Business Quant, National Healthcare's Current Deferred Revenue tumbled by 2131.9% in 2021 and then plummeted by 9948.91% in 2022.
  • National Healthcare's Current Deferred Revenue (Quarter) stood at $51.3 million in 2020, then tumbled by 70.69% to $15.0 million in 2021, then crashed by 99.08% to $138000.0 in 2022, then soared by 5455.8% to $7.7 million in 2024.
  • Its last three reported values are $7.7 million in Q1 2024, $138000.0 for Q3 2022, and $586000.0 during Q2 2022.